Galunisertib downregulates mutant type I collagen expression and promotes MSCs osteogenesis in pediatric osteogenesis imperfecta.

Saved in:
Bibliographic Details
Title: Galunisertib downregulates mutant type I collagen expression and promotes MSCs osteogenesis in pediatric osteogenesis imperfecta.
Authors: Infante A; Stem Cells and Advanced Therapies Group, Biobizkaia Health Research Institute, Barakaldo, Spain., Alcorta-Sevillano N; Stem Cells and Advanced Therapies Group, Biobizkaia Health Research Institute, Barakaldo, Spain; Department of Cell Biology and Histology, University of Basque Country UPV/EHU, Leioa, Spain., Macías I; Stem Cells and Advanced Therapies Group, Biobizkaia Health Research Institute, Barakaldo, Spain., Cabodevilla L; Stem Cells and Advanced Therapies Group, Biobizkaia Health Research Institute, Barakaldo, Spain., Medhat D; Medical Biochemistry Department, National Research Centre, Dokki, Giza, Egypt., Lafaver B; Department of Biochemistry, University of Missouri, Columbia, USA., Crawford TK; Department of Biochemistry, University of Missouri, Columbia, USA., Phillips CL; Department of Biochemistry, University of Missouri, Columbia, USA., Bueno AM; Department of Orthopedic Surgery, Getafe University Hospital, Madrid, Spain., Sagastizabal B; Department of Endocrinology, Getafe University Hospital, Madrid, Spain., Arroyo M; Department of Traumatology, Basurto Hospital, Bilbao, Spain., Campino A; Service of Pharmacy, Cruces University Hospital, Barakaldo, Spain., Gerovska D; Computational Biology and Systems Biomedicine Research Group, Biogipuzkoa Health Research Institute, Donostia, Spain., Araúzo-Bravo M; Computational Biology and Systems Biomedicine Research Group, Biogipuzkoa Health Research Institute, Donostia, Spain; IKERBASQUE, Basque Foundation for Science, Bilbao 48009, Spain; Department of Cell Biology and Histology, Faculty of Medicine and Nursing, University of Basque Country (UPV/EHU), Spain., Gener B; Stem Cells and Advanced Therapies Group, Biobizkaia Health Research Institute, Barakaldo, Spain; Service of Genetics, Cruces University Hospital, Barakaldo, Spain., Rodríguez CI; Stem Cells and Advanced Therapies Group, Biobizkaia Health Research Institute, Barakaldo, Spain. Electronic address: cirodriguez@osakidetza.eus.
Source: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2024 Jun; Vol. 175, pp. 116725. Date of Electronic Publication: 2024 May 13.
Publication Type: Journal Article
Journal Info: Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 8213295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1950-6007 (Electronic) Linking ISSN: 07533322 NLM ISO Abbreviation: Biomed Pharmacother Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1950-6007
DOI:10.1016/j.biopha.2024.116725